NORTH AMERICA EUBIOTICS MARKET 2021-2028

Lifesciences | Healthcare & Wellness

NORTH AMERICA EUBIOTICS MARKET 2021-2028

Market by Type, Form, Livestock, Application, End-user, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report has ascertained that the North American eubiotics market is predicted to develop at a compound annual growth rate of 7.15% through the calculated years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries discussed in this market are:

•        United States

•        Canada

Chicken consumption has surpassed beef over the past years across the region. Moreover, pork is estimated to emerge as a popular meat product in the US in the next few years. Furthermore, Americans are likely to consume a higher amount of broiler chickens by 2030, as per the USDA and Economic Research Service estimate. Other than this, the growing concerns relating to meat quality and its influence on health have enhanced the demand for eubiotics across the region. Above all, the surge in concerns pertaining to zoonotic diseases among animals is majorly driving the development of the eubiotics market across the region.

Likewise, the chicken consumption rate has increased over the years within Canada. As a result, the production of chicken meat reached an all-time high in 2019. Additionally, animal agriculture is crucial for the country’s prosperity. Hence, the Canadian Pork Council and the meat, dairy, and poultry industries are striving to protect farms and the livelihoods of producers from the threat of multi-species infectious diseases. Therefore, the rise in meat consumption, along with rising concerns relating to food safety, zoonotic diseases, antimicrobial stewardship, and animal health, is likely to motivate the progression of the Canadian eubiotics market over the near future.

Lallemand Inc develops, produces, and distributes high-value year and bacteria products, including yeast derivatives. These solutions positively impact animal nutrition, forage management, and the animal environment. It caters to animal nutrition, baking, fermented beverages, health, and pharmaceutical sectors. Lallemand has operations across various regions, with headquarters located in Ontario, Canada. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA EUBIOTICS MARKET - SUMMARY    

2. INDUSTRY OUTLOOK  

2.1. IMPACT OF COVID-19 ON EUBIOTICS MARKET    

2.2. KEY INSIGHTS      

2.2.1. EUBIOTICS AS AN ALTERNATIVE TO ANTIBIOTICS

2.2.2. APPLICATIONS OF EUBIOTICS IN CALVES' GUT HEALTH

2.2.3. DEVELOPING FOOD ADDITIVE PLATFORM BASED ON GRAINS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTES         

2.3.3. BARGAINING POWER OF BUYERS      

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS INDEX  

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. MERGERS & ACQUISITIONS      

2.6.2. CONTRACTS & AGREEMENTS  

2.6.3. PRODUCT LAUNCHES    

2.6.4. EXPANSIONS         

2.7. MARKET DRIVERS         

2.7.1. RISING MEAT CONSUMPTION   

2.7.2. GROWING AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH     

2.7.3. INCREASING DEMAND FOR MANUFACTURED FEEDS     

2.8. MARKET CHALLENGES

2.8.1. UNAWARENESS ABOUT EUBIOTICS   

2.9. MARKET OPPORTUNITIES       

2.9.1. GOVERNMENT SUPPORT FOR EUBIOTICS USE     

2.9.2. PROBIOTICS SPRAY COATINGS           

2.9.3. ESSENTIAL OILS FOR NECROTIC ENTERITIS          

3. NORTH AMERICA EUBIOTICS MARKET OUTLOOK - BY TYPE

3.1. PROBIOTICS         

3.2. ORGANIC ACID    

3.3. PREBIOTICS         

3.4. ESSENTIAL OILS 

4. NORTH AMERICA EUBIOTICS MARKET OUTLOOK - BY FORM          

4.1. DRY 

4.2. LIQUID        

5. NORTH AMERICA EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK

5.1. SWINE        

5.2. POULTRY  

5.3. RUMINANTS         

5.4. AQUACULTURE   

5.5. OTHER LIVESTOCK        

6. NORTH AMERICA EUBIOTICS MARKET OUTLOOK - BY APPLICATION       

6.1. GUT HEALTH        

6.2. IMMUNITY  

6.3. YIELD MANAGEMENT    

6.4. OTHER APPLICATIONS 

7. NORTH AMERICA EUBIOTICS INDUSTRY OUTLOOK - BY END-USER

7.1. ANIMALS    

7.2. HUMANS    

8. NORTH AMERICA EUBIOTICS MARKET – REGIONAL OUTLOOK       

8.1. UNITED STATES

8.2. CANADA                

9. COMPETITIVE LANDSCAPE 

9.1. ANPARIO PLC                  

9.2. ARCHER DANIELS MIDLAND   

9.3. BASF SE                

9.4. BEHN MEYER GROUP               

9.5. BENEO GMBH                  

9.6. CARGILL INC        

9.7. CHR HANSEN HOLDING AS                 

9.8. DUPONT DE NEMOURS INC    

9.9. KEMIN INDUSTRIES INC

9.10. KONINKLIJKE DSM NV            

9.11. LALLEMAND INC           

9.12. LESAFFRE          

9.13. NEOSPARK DRUGS AND CHEMICALS PRIVATE LIMITED                     

9.14. NOVUS INTERNATIONAL INC

9.15. YARA INTERNATIONAL ASA              

10. RESEARCH METHODOLOGY & SCOPE  

10.1. RESEARCH SCOPE & DELIVERABLES                  

10.2. SOURCES OF DATA                 

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: COUNTRIES WITH THE HIGHEST ANNUAL MEAT CONSUMPTION

TABLE 4: MAJOR LIVESTOCK DISEASES IN THE WORLD

TABLE 5: NORTH AMERICA EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 9: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: NORTH AMERICA EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: NORTH AMERICA EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $ MILLION)

FIGURE 4: NORTH AMERICA EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $ MILLION)

FIGURE 5: NORTH AMERICA EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $ MILLION)

FIGURE 6: NORTH AMERICA EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)

FIGURE 8: NORTH AMERICA EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028 (IN %)

FIGURE 11: NORTH AMERICA EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 17: NORTH AMERICA EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 22: NORTH AMERICA EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 25: UNITED STATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: CANADA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying